Coeptis Therapeutics Congratulates Alexander Deiters, Professor at the University of Pittsburgh, on Receiving the 2024 Chancellor's Distinguished Research Award

WEXFORD, Pa., April 2, 2024 /PRNewswire/ -- Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) ("Coeptis" or "the Company"), a biopharmaceutical company developing innovative cell therapy platforms fo

Coeptis TherapeuticsApr 2 00:00 ET

12 Health Care Stocks Moving In Tuesday's After-Market Session

GainersApollomics (NASDAQ:APLM) stock rose 10.9% to $0.61 during Tuesday's after-market session. The market value of their outstanding shares is at $54.5 million. Cara Therapeutics (NASDAQ:CARA) share

BenzingaMar 26 17:32 ET

Coeptis Expands License for CAR Technology to Autoimmune Diseases

Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP), a biopharmaceutical company, announced today an expansion of its exclusive license agreement with the University of Pittsburgh.

Investing.com Feb 26 10:40 ET

Express News | Coeptis Therapeutics Adds Autoimmune Indications To Exclusive License Agreement With University Of Pittsburgh For SNAP-CAR T And SNAP-CAR NK

Moomoo 24/7Feb 26 09:02 ET

Coeptis Therapeutics Adds Autoimmune Indications to Exclusive License Agreement With University of Pittsburgh for SNAP-CAR T and SNAP-CAR NK

Exclusive rights to universal CAR technology platform designed to target multiple antigens simultaneously, recently expanded to include SNAP-CAR NK cells, has potential to impact various autoimmune di

Coeptis TherapeuticsFeb 26 00:00 ET

Biotech With Potential: Coeptis Therapeutics (COEP) And 3 Underrated Gems

Globe PR WireFeb 21 17:43 ET